Upwards arrow: Go back to top

Join us on LinkedIn for the latest news.

We use cookies to improve the user experience.
You can read more about our Cookie Policy here.
Accept

Tuesday, February 4, 2025

Auron Therapeutics secures FDA clearance & $27M Series B to advance precision oncology